Literature DB >> 2643719

Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients.

W K Mebust1, H L Holtgrewe, A T Cockett, P C Peters.   

Abstract

The mortality rate for transurethral prostatectomy was 0.2 per cent in 3,885 patients reviewed retrospectively. The immediate postoperative morbidity rate was 18 per cent. Increased morbidity was found in patients with a resection time of more than 90 minutes, gland size of more than 45 gm., acute urinary retention and patient age greater than 80 years, and in the black population. Of the patients 77 per cent had significant pre-existing medical problems. Operative mortality, significant morbidity and hospital stay were reduced in comparison to studies done 15 and 30 years ago.

Entities:  

Mesh:

Year:  1989        PMID: 2643719     DOI: 10.1016/s0022-5347(17)40731-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  165 in total

Review 1.  Transurethral microwave thermotherapy in benign prostatic hyperplasia.

Authors:  P Minnee; F M Debruyne; J J de la Rosette
Journal:  Curr Urol Rep       Date:  2000-08       Impact factor: 3.092

2.  Ascites following prostatectomy: a rare presentation of comorbid disease.

Authors:  Güven Aslan; Müjde Soytürk; Aykut Kefi; Ilhan Celebi; Hale Akpinar
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

3.  BPH: predicting TWOC failure in acute urinary retention.

Authors:  Bob Djavan; Amir Kazzazi; Herbert Lepor
Journal:  Nat Rev Urol       Date:  2012-02-28       Impact factor: 14.432

4.  TURP in the new century: an analytical reappraisal in light of lasers.

Authors:  Assaad El-Hakim
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

Review 5.  Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors:  M I Wilde; A Fitton; E M Sorkin
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 6.  Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors:  M I Wilde; A Fitton; D McTavish
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 7.  Technical aspects of holmium laser enucleation of the prostate for benign prostatic hyperplasia.

Authors:  Myong Kim; Hahn-Ey Lee; Seung-June Oh
Journal:  Korean J Urol       Date:  2013-09-10

8.  The changing practice of transurethral resection of the prostate.

Authors:  M J Young; M Elmussareh; T Morrison; J R Wilson
Journal:  Ann R Coll Surg Engl       Date:  2018-03-15       Impact factor: 1.891

Review 9.  Evaluating the efficacy, safety, and cost of lasers for the treatment of benign prostatic hyperplasia.

Authors:  C M Dixon
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

10.  Are indications for prostatectomy in octogenarians the same as for younger men?

Authors:  Andrei Nadu; Nicola J Mabjeesh; Jacob Ben-Chaim; Issac Kaver; Haim Matzkin; Alexander Greenstein
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.